STAT+: Pharmalittle: Biden urged by former FDA commissioners to pick agency chief; Lilly reports more positive data for Covid-19 drug
Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made is this far, which is a likely sign of surviving another few days. And of course, no prescription is required, which is a good thing. And while you drink up, you can peruse some of the tidbits we have assembled to help you start the day. Hope you conquer the world and, as always, do keep in touch …
Drug makers are crafting Covid-19 vaccines that would target more than one strain of the virus, hoping to strengthen the immunization campaign against the pathogen as it evolves, The Wall Street Journal writes. Researchers at Moderna (MRNA) and Novavax (NVAX) and the University of Oxford are designing the shots, known as multivalent vaccines, to protect not only against the form of the virus commonly circulating globally but also potentially contagious strains that have emerged or might in the future.
Continue to STAT+ to read the full story…
